Proflazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401545This classification denotes a benzodiazepine with the molecular formula C18H16ClFN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 545MN0F125, chemically known as 7-chloro-1-(2,3-dihydroxypropyl)-5-(o-fluorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one but generally known as proflazepam, which bears US NIH Compound Identifier 3050433. European Medicines Agency schedules Proflazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10074MIG. The term PROFLAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). PROFLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proflazepam under HS 29339940 and SITC 51577. As of Q4 2014, PROFLAZEPAM remains the US FDA Preferred Term for this commodity. Proflazepam bears US NLM identifiers UMLS ID C1882473 and NCI Concept Code C66476. SMILES: CLC1CC2C(N(CC(O)CO)C(=O)CN=C2C2C(F)CCCC2)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.